Baxter International (BAX)
NYSE: BAX · Medical Devices · Deerfield, IL
Our rating: Positive
Call changed from Neutral to Positive at $23.00, moderate conviction, October 30, 2026.
Breaks if: The positive call rests on free cash flow holding near current levels. It breaks if reported free cash flow falls below $600M in either of the next two annual reporting periods — a roughly 30% decline that would signal real cash deterioration rather than a non-cash accounting drag, and would remove the primary support for the valuation argument.
Key figures
| Market value | $13.1B |
|---|---|
| Revenue, last 12 months | $11.6B |
| Net income, last 12 months | −$723M |
| Free cash flow, last 12 months | n/a |
| Price to earnings | n/a |
| Free cash flow yield | n/a |
| Dividend yield | 0.2% |
| Operating margin | −1.9% |
| Return on equity | −10.5% |
| Beta to the S&P 500 | 0.84 |
| Volatility, annualized | 40.0% |
Reported quarters
| Quarter ending | Revenue | Year on year | Earnings per share | Free cash flow |
|---|---|---|---|---|
| September 30, 2026 | $3.0B | 5.0% | $0.57 | n/a |
| June 30, 2026 | $3.0B | 5.3% | $0.24 | n/a |
| March 31, 2026 | $2.7B | 2.9% | $-0.03 | n/a |
| December 31, 2025 | $3.0B | 8.0% | $-2.20 | n/a |
| September 30, 2025 | $2.8B | 5.0% | $-0.09 | n/a |
| June 30, 2025 | $2.8B | 4.3% | $0.18 | n/a |
| March 31, 2025 | $2.6B | 5.4% | $0.25 | n/a |
| December 31, 2024 | $2.8B | 0.9% | $-1.00 | n/a |
Three-model forecasts for the next quarter
Written November 21, 2026, before the report. Each settles from the SEC filing.
- Revenue for the quarter is at least $3.13B: Claude 52%, Gemini 85%, Mistral 55%
- Diluted earnings per share are above zero: Claude 72%, Gemini 90%, Mistral 80%
- Backlog at the end of the quarter is at least $7.58B: Claude 40%, Gemini 30%, Mistral 40%
12 ledger entries and 68 corporate events on record. Share price as of November 20, 2026. Research and education only. Not investment advice. Stoquity does not manage money or know your circumstances. Ratings, forecasts and lists are produced by software and AI models and can be wrong. Performance figures are hypothetical, measured on paper against a benchmark, and say nothing certain about the future.